Drug Trial Radar · NCT07076459
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Aug 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Jul 10, 2025
Primary completion
Aug 18, 2025
Study completion Aug 18, 2025
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the pharmacokinetic characteristics of HR091506 tablets in different batches in healthy subjects after single administration.
Conditions
- Health Volunteer
Interventions
HR091506 tabletDrug
In each period under fed conditions, subjects received oral administration of either HR091506 tablet(T1), HR091506 tablet(T2), or HR091506 tablet(R).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax: Maximum plasma concentration. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
- AUC0-t: Area under the plasma concentration-time curve from time 0 to the time of the last quantifiable concentration. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
- AUC0-∞: Area under the plasma concentration-time curve from time 0 to infinity. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
- Tmax: Observed time to reach Cmax. Blood samples will be collected.Time frame: From 0 hour predose up to 36 hours postdose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cangzhou Central Hospital
Cangzhou, Hebei, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.